Aurinia Pharmaceuticals Inc - Common Shares (AUPH)
NASDAQ · Healthcare
$15.25-4.45%
As of Jul 20, 2026
Price history
Key statistics
- Market cap
- $2.05B
- P/E ratio
- —
- EPS
- —
- Volume
- 999,492
- 52-week high
- —
- 52-week low
- —
- Open
- $15.98
- Day high
- $16.14
- Day low
- $15.23
Financial highlights
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| 2025 | $62.47M | $23.34M | $0.16 |
| 2024 | $50.3M | -$10.75M | -$0.07 |
| 2023 | $175.51M | -$78.02M | -$0.54 |
| 2022 | $134.03M | -$108.18M | -$0.76 |
| 2021 | $45.61M | -$180.97M | -$1.40 |
About Aurinia Pharmaceuticals Inc - Common Shares
Aurinia Pharmaceuticals Inc. operates as a commercial-stage biopharmaceutical company, specializing in the development and commercialization of innovative therapies. Its core mission is to address a variety of diseases for which current medical solutions are inadequate, serving patient populations across the United States and internationally. The company's flagship product is LUPKYNIS, an approved treatment designed for adult individuals suffering from active lupus nephritis. Furthermore, Aurinia maintains a strategic collaboration and licensing agreement with Otsuka Pharmaceutical Co., Ltd. The firm's main corporate office is located in Victoria, Canada.
- CEO
- Kevin C. Tang
- Employees
- 128
- Country
- CA
- IPO date
- Sep 3, 2014
Similar stocks
Other Healthcare companies
Frequently asked questions
- What is Aurinia Pharmaceuticals Inc - Common Shares's stock price today?
- AUPH is trading at $15.25 as of Jul 20, 2026.
- What is Aurinia Pharmaceuticals Inc - Common Shares's market cap?
- Aurinia Pharmaceuticals Inc - Common Shares (AUPH) has a market capitalization of $2.05B.
- Does Aurinia Pharmaceuticals Inc - Common Shares pay a dividend?
- Aurinia Pharmaceuticals Inc - Common Shares did not pay a dividend in its most recent reported fiscal year.
- What sector is Aurinia Pharmaceuticals Inc - Common Shares in?
- Aurinia Pharmaceuticals Inc - Common Shares operates in the Healthcare sector.